This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Gil Medical Center. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jee-Hyun Um and Research on BMP10
Introduction
Jee-Hyun Um is an inventor associated with Busan, South Korea, and Gil Medical Center. Her patent work explores the potential of bone morphogenetic protein 10 (BMP10) in addressing metabolic health concerns.
Latest Patents
The available information lists 1 patent for Jee-Hyun Um: “Method for Reducing Insulin Resistance or Total Blood Cholesterol Levels by Administering Bone Morphogenetic Protein 10.” The patent describes methods that involve parenterally administering a pharmaceutical composition containing BMP10 to a subject. In a high-fat-diet-induced obese animal model, BMP10 administration lowered fasting blood glucose and insulin secretion compared with a control, findings that indicate improved insulin resistance. The treatment also reduced total blood cholesterol levels relative to the control.
Career Highlights
Um’s listed work connects biomedical research with potential therapeutic applications for insulin resistance and elevated cholesterol. Her affiliation with Gil Medical Center provides the institutional context for this research.
Collaborations
The listed coworkers associated with Um include Cheol Soo Choi and Shi-Young Park.
Conclusion
Jee-Hyun Um’s patent describes a potential BMP10-based approach to reducing insulin resistance and total blood cholesterol, reflecting her contribution to biomedical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile